These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2874759)

  • 41. Reversibility test in the early stages of bronchial asthma.
    Mariotta S; Sposato B; Ricci A; Bruno P; Aquilini M; Mannino F
    J Asthma; 2005; 42(6):487-91. PubMed ID: 16293544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smoking, lung function, and body weight.
    Nemery B; Moavero NE; Brasseur L; Stănescu DC
    Br Med J (Clin Res Ed); 1983 Jan; 286(6361):249-51. PubMed ID: 6402057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of smoking on the decline in forced expiratory volume in one second].
    Sato K; Kioi S; Arakawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Mar; 35(3):288-93. PubMed ID: 9168644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.
    Tirimanna PR; Den Otter JJ; Van Schayck CP; Van Herwaarden CL; Folgering H; Van Weel C
    Br J Gen Pract; 1996 Jan; 46(402):15-8. PubMed ID: 8745846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Early detection of chronic obstructive pulmonary disease by following individual annual changes in lung function].
    Ichinose Y; Kasuga I; Minemura K; Kiyokawa H; Utsumi K; Torii Y; Yonemaru M; Toyama K; Naruto M; Noro M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1109-13. PubMed ID: 8255020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables.
    Eliasson O; Degraff AC
    Am Rev Respir Dis; 1985 Oct; 132(4):858-64. PubMed ID: 4051321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 1-second forced expiratory volume and density dependence in early airflow limitation.
    Teculescu DB; Bohadana AB; Peslin R; Cereceda JV
    Respiration; 1983; 44(6):433-8. PubMed ID: 6648052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects.
    Tweeddale PM; Alexander F; McHardy GJ
    Thorax; 1987 Jul; 42(7):487-90. PubMed ID: 3438892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance of airflow obstruction after thoracoplasty.
    Phillips MS; Miller MR; Kinnear WJ; Gough SE; Shneerson JM
    Thorax; 1987 May; 42(5):348-52. PubMed ID: 3660288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of long-term changes in airway function.
    Pride NB
    Agents Actions Suppl; 1990; 30():21-34. PubMed ID: 2239531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ventilatory impairment and hypoxemia in chronic non-specific lung disease.
    Teculescu D; Manicatide M; Racoveanu C
    Bull Eur Physiopathol Respir; 1976; 12(6):735-45. PubMed ID: 1016801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The natural history of chronic airflow obstruction.
    Fletcher C; Peto R
    Br Med J; 1977 Jun; 1(6077):1645-8. PubMed ID: 871704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The long-term course of airflow obstruction in obstructive variants of the fibrotic stage of sarcoidosis and of idiopathic pulmonary fibrosis.
    Meier-Sydow J; Rust MG; Kappos A; Kronenberger H; Nerger K; Schultze-Werninghaus G
    Ann N Y Acad Sci; 1986; 465():515-22. PubMed ID: 3460392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation.
    Peto R; Speizer FE; Cochrane AL; Moore F; Fletcher CM; Tinker CM; Higgins IT; Gray RG; Richards SM; Gilliland J; Norman-Smith B
    Am Rev Respir Dis; 1983 Sep; 128(3):491-500. PubMed ID: 6614643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of lung function and mode of inhalation on penetration of aerosol into the human lung.
    Pavia D; Thomson ML; Clarke SW; Shannon HS
    Thorax; 1977 Apr; 32(2):194-7. PubMed ID: 867333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlates of FEV1 and prevalence of pulmonary conditions in Japanese-American men.
    Marcus EB; Buist AS; Curb JD; MacLean CJ; Reed DM; Johnson LR; Yano K
    Am Rev Respir Dis; 1988 Dec; 138(6):1398-404. PubMed ID: 3202494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lung compliance and its transient elevations measured with pulse-flow method.
    Suratt PM; Owens DH; Hsiao H; Kaiser DL; Rochester DF
    J Appl Physiol Respir Environ Exerc Physiol; 1981 Jun; 50(6):1318-24. PubMed ID: 7263395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study.
    Franzen DP; Nowak A; Haile SR; Mottet D; Bonani M; Dormond O; Kohler M; Krayenbuehl PA; Barbey F
    PLoS One; 2017; 12(7):e0180437. PubMed ID: 28742806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversibility of pulmonary function abnormalities in smokers. A prospective study of early diagnostic tests of small airways disease.
    Bode FR; Dosman J; Martin RR; Macklem PT
    Am J Med; 1975 Jul; 59(1):43-52. PubMed ID: 1138550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early emphysema. Ten years' evolution.
    Demedts M; Aumann J
    Chest; 1988 Aug; 94(2):337-42. PubMed ID: 3396413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.